Improving patient care by "personalizing" the practice of medicine often results from studying specific drugs and their impact of genetic biomarkers. New research underway at GW by Travis O'Brien, PhD, looks at the drug warfarin, an oral anticoagulant used to treat individuals with certain cardiovascular diseases warfarin accounts for several million prescriptions each year.
More...